Time to Stop Using Ineffective Covid-19 Drugs
Author:
Affiliation:
1. From the Centre for the AIDS Programme of Research in South Africa, Durban (S.S.A.K., N.D.); and the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York (S.S.A.K.).
Publisher
Massachusetts Medical Society
Subject
General Medicine
Link
http://www.nejm.org/doi/pdf/10.1056/NEJMe2209017
Reference8 articles.
1. Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19
2. Fluvoxamine in Nonhospitalized Patients With Acute COVID-19 Infection and the Lack of Efficacy in Reducing Rates of Hospitalization, Mechanical Ventilation, and Mortality in Placebo-Controlled Trials: A Systematic Review and Meta-Analysis
3. Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients
4. The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19
5. Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mechanisms of antiviral action and toxicities of ipecac alkaloids: Emetine and dehydroemetine exhibit anti-coronaviral activities at non-cardiotoxic concentrations;Virus Research;2024-03
2. Even one dose of tocilizumab could hinder bad prognosis of cytokines storm in COVID-19 patients;Cytokine;2024-01
3. Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19;International Journal of Molecular Sciences;2023-12-01
4. Off-label drug use during the COVID-19 pandemic in Africa: topic modelling and sentiment analysis of ivermectin in South Africa and Nigeria as a case study;Journal of The Royal Society Interface;2023-09
5. Modeling the dynamics of COVID-19 with real data from Thailand;Scientific Reports;2023-08-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3